375 / 1631
UKLG LY09
• RT significantly improved
EFS in subsets of
• Advanced stage
• ABVD or other
• Bulk or not
• LMA or not
• CR to chemo or not
Johnson P et al J Clin Oncol. 2010 Jul 10;28(20):3352-9
|
|
375 / 1631
UKLG LY09
• RT significantly improved
EFS in subsets of
• Advanced stage
• ABVD or other
• Bulk or not
• LMA or not
• CR to chemo or not
Johnson P et al J Clin Oncol. 2010 Jul 10;28(20):3352-9